Jacob Chacko, President and CEO at Oric Pharmaceuticals, Inc. (ORIC), sold 9,738 shares at $25.07 ($245K) on 2021-05-20, disclosed to the SEC on 2021-05-24.
Open-market sale of $245k ORIC by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.07 | 2,468 | $62K | 25.3% |
| 2 | $25.07 | 2,468 | $62K | 25.3% |
| 3 | $25.20 | 4,790 | $121K | 49.3% |
| 4 | $25.00 | 12 | $300 | 0.1% |
| Total | $25.13 avg | 9,738 | $245K | 100% |
| Filing → |
| ORIC | SELL | 2025-10-02 | $2.1M | — | Filing → |
| ORIC | SELL | 2025-09-24 | $1.4M | — | Filing → |
| ORIC | SELL | 2024-12-17 | $408K | — | Filing → |